Zymark Acquisition Would Enable Caliper Profitability By Year-End 2005
This article was originally published in The Gray Sheet
Executive Summary
Caliper's existing distribution channels with diagnostics and life sciences manufacturers such as Bio-Rad and Agilent will remain unaffected by the firm's $72.7 mil. cash and stock purchase of Zymark